Home  |  Contact

Cellosaurus NCH421k (CVCL_X910)

[Text version]

Cell line name NCH421k
Synonyms NCH421K
Accession CVCL_X910
Resource Identification Initiative To cite this cell line use: NCH421k (RRID:CVCL_X910)
Disease Glioblastoma (NCIt: C3058)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 66Y
Category Cancer cell line
STR profile Source(s): CLS

Markers:
AmelogeninX,Y
CSF1PO10,11
D3S135814,16
D5S81811,13
D7S82010,12
D8S117912,15
D13S3178,11
D16S53910,11
D18S5113
D21S1130
FGA21,25
Penta D9,13
Penta E7,12
TH016
TPOX8,11
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=20442299; DOI=10.1158/1078-0432.CCR-09-1800
Campos B., Wan F., Farhadi M., Ernst A., Zeppernick F., Tagscherer K.E., Ahmadi R., Lohr J., Dictus C., Gdynia G., Combs S.E., Goidts V., Helmke B.M., Eckstein V., Roth W., Beckhove P., Lichter P., Unterberg A., Radlwimmer B., Herold-Mende C.
Differentiation therapy exerts antitumor effects on stem-like glioma cells.
Clin. Cancer Res. 16:2715-2728(2010)

PubMed=24294177; DOI=10.2478/raon-2013-0063
Podergajs N., Brekka N., Radlwimmer B., Herold-Mende C., Talasila K.M., Tiemann K., Rajcevic U., Lah T.T., Bjerkvig R., Miletic H.
Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF.
Radiol. Oncol. 47:330-337(2013)

Cross-references
Cell line collections CLS; 300118/p803_NCH421K
Other Wikidata; Q54907705
Entry history
Entry creation05-Sep-2014
Last entry updated13-Nov-2018
Version number5